Pages that link to "Q43516427"
Jump to navigation
Jump to search
The following pages link to Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children (Q43516427):
Displaying 50 items.
- Pediatric vulvovaginal disorders: a diagnostic approach and review of the literature (Q30921028) (← links)
- Childhood atopic eczema (Q31071262) (← links)
- Therapeutic options for chronic hand dermatitis (Q34325706) (← links)
- What's new in atopic dermatitis? (Q34352747) (← links)
- Topical tacrolimus for the treatment of inflammatory skin diseases (Q34388615) (← links)
- Recent advances in dermatology (Q34503639) (← links)
- New treatments for atopic dermatitis (Q34592295) (← links)
- Tacrolimus: a review of its use for the management of dermatoses (Q34668921) (← links)
- Eosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitis (Q34882570) (← links)
- New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications (Q34999538) (← links)
- Treatment of atopic dermatitis and impact on quality of life: a review with emphasis on topical non-corticosteroids (Q35056734) (← links)
- Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies (Q35077866) (← links)
- International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategies (Q35106685) (← links)
- Tacrolimus ointment for the management of atopic dermatitis (Q35121501) (← links)
- The treatment of atopic dermatitis with topical immunomodulators (Q35143063) (← links)
- A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis (Q35171524) (← links)
- Complementary therapy for atopic eczema and other allergic skin diseases (Q35199979) (← links)
- Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches (Q35603170) (← links)
- Macrolactam immunomodulators (tacrolimus and pimecrolimus): new horizons in the topical treatment of inflammatory skin diseases (Q35922000) (← links)
- Recent advances in treatment strategies for atopic dermatitis (Q38635240) (← links)
- The role of topical calcineurin inhibitors in atopic dermatitis (Q35952647) (← links)
- Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis (Q36042131) (← links)
- New treatment modalities for vitiligo: focus on topical immunomodulators (Q36055444) (← links)
- Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions (Q36093284) (← links)
- The economics of topical immunomodulators for the treatment of atopic dermatitis. (Q36165229) (← links)
- Platycodon grandiflorus alleviates DNCB-induced atopy-like dermatitis in NC/Nga mice (Q36313468) (← links)
- Topical tacrolimus in the management of atopic dermatitis in Japan (Q36466798) (← links)
- A systematic review of the safety of topical therapies for atopic dermatitis. (Q36708358) (← links)
- A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis. (Q36784236) (← links)
- Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice (Q36892767) (← links)
- Coal tar in dermatology (Q36939616) (← links)
- The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review (Q36940038) (← links)
- Topical calcineurin inhibitors in pediatric atopic dermatitis: a critical analysis of current issues (Q36967207) (← links)
- Food allergy: transfused and transplanted (Q37738093) (← links)
- The Safety and Efficacy of Tacrolimus Ointment in Pediatric Patients with Atopic Dermatitis (Q37777179) (← links)
- Update on the management of chronic eczema: new approaches and emerging treatment options (Q37857682) (← links)
- FK506 regulates pigmentation by maturing the melanosome and facilitating their transfer to keratinocytes (Q38818661) (← links)
- Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults (Q39315300) (← links)
- Tacrolimus ointment in the management of atopic dermatitis (Q42081579) (← links)
- Topical tacrolimus as treatment of atopic dermatitis (Q42263734) (← links)
- Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic CONTROL study (Q42633680) (← links)
- Risk: benefit ratio is important in treating atopic dermatitis (Q42780200) (← links)
- Tacrolimus ointment: advancing the treatment of atopic dermatitis (Q43916746) (← links)
- New horizons in the treatment of atopic dermatitis (Q43978428) (← links)
- Antipruritic effects of pimecrolimus and tacrolimus (Q44420847) (← links)
- Long term management of childhood atopic dermatitis with calcineurin inhibitors (Q44420855) (← links)
- Practice experience with topical calcineurin inhibitors (Q44420871) (← links)
- Safe treatment of head/neck AD with tacrolimus ointment (Q44458991) (← links)
- Cost-effectiveness of tacrolimus ointment in adults and children with moderate and severe atopic dermatitis: twice-weekly maintenance treatment vs. standard twice-daily reactive treatment of exacerbations from a third party payer (U.K. National Heal (Q44513075) (← links)
- An open‐label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema (Q44604968) (← links)